Trans-1,3,3,3-tetrafluoroprop-1-ene; Exemption From the Requirement of a Tolerance, 61118-61122 [2015-25690]

Agencies

• ENVIRONMENTAL PROTECTION AGENCY

[Federal Register Volume 80, Number 196 (Friday, October 9, 2015)]
[Rules and Regulations]
[Pages 61118-61122]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-25690]


-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

40 CFR Part 180

[EPA-HQ-OPP-2012-0043; FRL-9934-74]


Trans-1,3,3,3-tetrafluoroprop-1-ene; Exemption From the 
Requirement of a Tolerance

AGENCY: Environmental Protection Agency (EPA).

ACTION: Final rule.

-----------------------------------------------------------------------

SUMMARY: This regulation establishes an exemption from the requirement 
of a tolerance for residues of trans-1,3,3,3-tetrafluoroprop-1-ene (CAS 
Reg. No. 29118-24-9) when used as an inert ingredient (propellant) in 
pesticide formulations applied to growing crops, raw agricultural 
commodities after harvest, and animals, and when used as an inert 
ingredient in antimicrobial pesticide formulations for food-contact 
surface sanitizing solutions. The Acta Group, L.L.C. on behalf of 
Honeywell International, Inc. submitted a petition to EPA under the 
Federal Food, Drug, and Cosmetic Act (FFDCA), requesting establishment 
of an exemption from the requirement of a tolerance. This regulation 
eliminates the need to establish a maximum permissible level for 
residues of trans-1,3,3,3-tetrafluoroprop-1-ene.

DATES: This regulation is effective October 9, 2015. Objections and 
requests for hearings must be received on or before December 8, 2015, 
and must be filed in accordance with the instructions provided in 40 
CFR part 178 (see also Unit I.C. of the SUPPLEMENTARY INFORMATION).

ADDRESSES: The docket for this action, identified by docket 
identification (ID) number EPA-HQ-OPP-2012-0043, is available at https://www.regulations.gov or at the Office of Pesticide Programs Regulatory 
Public Docket (OPP Docket) in the Environmental Protection Agency 
Docket Center (EPA/DC), West William Jefferson Clinton Bldg., Rm. 3334, 
1301 Constitution Ave. NW., Washington, DC 20460-0001. The Public 
Reading Room is open from 8:30 a.m. to 4:30 p.m.,

[[Page 61119]]

Monday through Friday, excluding legal holidays. The telephone number 
for the Public Reading Room is (202) 566-1744, and the telephone number 
for the OPP Docket is (703) 305-5805. Please review the visitor 
instructions and additional information about the docket available at 
https://www.epa.gov/dockets.

FOR FURTHER INFORMATION CONTACT: Susan Lewis, Registration Division 
(7505P), Office of Pesticide Programs, Environmental Protection Agency, 
1200 Pennsylvania Ave. NW., Washington, DC 20460-0001; main telephone 
number: (703) 305-7090; email address: RDFRNotices@epa.gov.

SUPPLEMENTARY INFORMATION: 

I. General Information

A. Does this action apply to me?

    You may be potentially affected by this action if you are an 
agricultural producer, food manufacturer, or pesticide manufacturer. 
The following list of North American Industrial Classification System 
(NAICS) codes is not intended to be exhaustive, but rather provides a 
guide to help readers determine whether this document applies to them. 
Potentially affected entities may include:
     Crop production (NAICS code 111).
     Animal production (NAICS code 112).
     Food manufacturing (NAICS code 311).
     Pesticide manufacturing (NAICS code 32532).

B. How can I get electronic access to other related information?

    You may access a frequently updated electronic version of 40 CFR 
part 180 through the Government Printing Office's e-CFR site at https://www.ecfr.gov/cgi-bin/text-idx?&c=ecfr&tpl=/ecfrbrowse/Title40/40tab_02.tpl.

C. How can I file an objection or hearing request?

    Under FFDCA section 408(g), 21 U.S.C. 346a, any person may file an 
objection to any aspect of this regulation and may also request a 
hearing on those objections. You must file your objection or request a 
hearing on this regulation in accordance with the instructions provided 
in 40 CFR part 178. To ensure proper receipt by EPA, you must identify 
docket ID number EPA-HQ-OPP-2012-0043 in the subject line on the first 
page of your submission. All objections and requests for a hearing must 
be in writing, and must be received by the Hearing Clerk on or before 
December 8, 2015. Addresses for mail and hand delivery of objections 
and hearing requests are provided in 40 CFR 178.25(b).
    In addition to filing an objection or hearing request with the 
Hearing Clerk as described in 40 CFR part 178, please submit a copy of 
the filing (excluding any Confidential Business Information (CBI)) for 
inclusion in the public docket. Information not marked confidential 
pursuant to 40 CFR part 2 may be disclosed publicly by EPA without 
prior notice. Submit the non-CBI copy of your objection or hearing 
request, identified by docket ID number EPA-HQ-OPP-2012-0043, by one of 
the following methods:
     Federal eRulemaking Portal: https://www.regulations.gov. 
Follow the online instructions for submitting comments. Do not submit 
electronically any information you consider to be CBI or other 
information whose disclosure is restricted by statute.
     Mail: OPP Docket, Environmental Protection Agency Docket 
Center (EPA/DC), (28221T), 1200 Pennsylvania Ave. NW., Washington, DC 
20460-0001.
     Hand Delivery: To make special arrangements for hand 
delivery or delivery of boxed information, please follow the 
instructions at https://www.epa.gov/dockets/contacts.html.
    Additional instructions on commenting or visiting the docket, along 
with more information about dockets generally, is available at https://www.epa.gov/dockets.

II. Petition for Exemption

    In the Federal Register of April 4, 2012 (77 FR 20334) (FRL-9340-
4), EPA issued a document pursuant to FFDCA section 408, 21 U.S.C. 
346a, announcing the filing of a pesticide petition (PP 1E7938) by The 
Acta Group, L.L.C. (2200 Pennsylvania Avenue NW., Suite 100W, 
Washington, DC 20037) on behalf of Honeywell International, Inc., 101 
Columbia Road, Morristown, NJ 07962. The petition requested that 40 CFR 
180.910, 180.930 and 180.940(a) be amended by establishing an exemption 
from the requirement of a tolerance for residues of trans-1,3,3,3-
tetrafluoroprop-1-ene (CAS Reg. No. 29118-24-9) when used as an inert 
ingredient (propellant) in pesticide formulations applied to growing 
crops, raw agricultural commodities after harvest, and animals, and 
when used as an inert ingredient in antimicrobial pesticide 
formulations for food-contact surface sanitizing solutions, 
respectively. That document referenced a summary of the petition 
prepared by The Acta Group, L.L.C. on behalf of Honeywell 
International, Inc., the petitioner, which is available in the docket, 
https://www.regulations.gov. There were no comments received in response 
to the notice of filing.

III. Inert Ingredient Definition

    Inert ingredients are all ingredients that are not active 
ingredients as defined in 40 CFR 153.125 and include, but are not 
limited to, the following types of ingredients (except when they have a 
pesticidal efficacy of their own): Solvents such as alcohols and 
hydrocarbons; surfactants such as polyoxyethylene polymers and fatty 
acids; carriers such as clay and diatomaceous earth; thickeners such as 
carrageenan and modified cellulose; wetting, spreading, and dispersing 
agents; propellants in aerosol dispensers; microencapsulating agents; 
and emulsifiers. The term ``inert'' is not intended to imply 
nontoxicity; the ingredient may or may not be chemically active. 
Generally, EPA has exempted inert ingredients from the requirement of a 
tolerance based on the low toxicity of the individual inert 
ingredients.

IV. Aggregate Risk Assessment and Determination of Safety

    Section 408(c)(2)(A)(i) of FFDCA allows EPA to establish an 
exemption from the requirement for a tolerance (the legal limit for a 
pesticide chemical residue in or on a food) only if EPA determines that 
the tolerance is ``safe.'' Section 408(b)(2)(A)(ii) of FFDCA defines 
``safe'' to mean that ``there is a reasonable certainty that no harm 
will result from aggregate exposure to the pesticide chemical residue, 
including all anticipated dietary exposures and all other exposures for 
which there is reliable information.'' This includes exposure through 
drinking water and in residential settings, but does not include 
occupational exposure. Section 408(b)(2)(C) of FFDCA requires EPA to 
give special consideration to exposure of infants and children to the 
pesticide chemical residue in establishing a tolerance and to ``ensure 
that there is a reasonable certainty that no harm will result to 
infants and children from aggregate exposure to the pesticide chemical 
residue. . . .''
    EPA establishes exemptions from the requirement of a tolerance only 
in those cases where it can be clearly demonstrated that the risks from 
aggregate exposure to pesticide chemical residues under reasonably 
foreseeable circumstances will pose no appreciable risks to human 
health. In order to determine the risks from aggregate exposure to 
pesticide inert ingredients, the Agency considers the toxicity of the 
inert in conjunction with possible exposure to residues of the

[[Page 61120]]

inert ingredient through food, drinking water, and through other 
exposures that occur as a result of pesticide use in residential 
settings. If EPA is able to determine that a finite tolerance is not 
necessary to ensure that there is a reasonable certainty that no harm 
will result from aggregate exposure to the inert ingredient, an 
exemption from the requirement of a tolerance may be established.
    Consistent with FFDCA section 408(c)(2)(A), and the factors 
specified in FFDCA section 408(c)(2)(B), EPA has reviewed the available 
scientific data and other relevant information in support of this 
action. EPA has sufficient data to assess the hazards of and to make a 
determination on aggregate exposure for trans-1,3,3,3-tetrafluoroprop-
1-ene including exposure resulting from the exemption established by 
this action. EPA's assessment of exposures and risks associated with 
trans-1,3,3,3-tetrafluoroprop-1-ene follows.

A. Toxicological Profile

    EPA has evaluated the available toxicity data and considered their 
validity, completeness, and reliability as well as the relationship of 
the results of the studies to human risk. EPA has also considered 
available information concerning the variability of the sensitivities 
of major identifiable subgroups of consumers, including infants and 
children. Specific information on the studies received and the nature 
of the adverse effects caused by trans-1,3,3,3-tetrafluoroprop-1-ene as 
well as the no-observed-adverse-effect-level (NOAEL) and the lowest-
observed-adverse-effect-level (LOAEL) from the toxicity studies are 
discussed in this unit.
    Acute inhalation toxicity is low for trans-1,3,3,3-tetrafluoroprop-
1-ene. Acute inhalation LD50s are >101,850 parts per million 
(ppm); approximately 713 milligram/kilogram (mg/kg) in rats and mice. 
Trans-1,3,3,3-tetrafluoroprop-1-ene is not a dermal irritant in rabbits 
or a sensitizer in humans.
    Two subchronic toxicity studies via the inhalation route of 
exposure are available for trans-1,3,3,3-tetrafluoroprop-1-ene in 
rodents. Toxicity is not observed in rats or mice at doses as high as 
5,000 ppm (approximately equivalent to 7,800 milligram/kilogram/day 
(mg/kg/day) human equivalent dose) following 13 weeks and 90 days of 
exposure, respectively. The 90-day inhalation toxicity study in mice 
also evaluated the carcinogenic potential of trans-1,3,3,3-
tetrafluoroprop-1-ene by conducting a toxicogenomic assessment. Trans-
1,3,3,3-tetrafluoroprop-1-ene is classified as non-carcinogenic by the 
toxicogenomic assessment at 10,000 ppm (approximately equivalent to 
15,600 mg/kg/day human equivalent dose), the highest dose tested (HDT).
    Developmental toxicity studies via the inhalation route are 
available in rats and rabbits. Neither maternal nor developmental 
toxicity is observed in either study up to 15,000 ppm (approximately 
equivalent to 23,400 mg/kg/day human equivalent dose), the HDT.
    Two Ames Tests via gas exposure are available for review with 
trans-1,3,3,3-tetrafluoroprop-1-ene. The mouse micronucleus assay was 
performed via inhalation exposure. These tests are negative.
    A chronic study with trans-1,3,3,3-tetrafluoroprop-1-ene is not 
available for review. Although a chronic toxicity study is not 
available, there is no concern for the lack of it because toxicity is 
not seen following up to 13 weeks of exposure to trans-1,3,3,3-
tetrafluoroprop-1-ene at excessive doses (7,800 and 15,600 mg/kg/day). 
Also, toxicity is not seen in the developmental study at an excessive 
dose of 23,400 mg/kg/day. Therefore, the likelihood that chronic 
exposure to doses below the limit dose will result in toxic effects is 
highly unlikely.
    Neurotoxicity studies are not available for review. However, 
evidence of neurotoxicity is not observed in the submitted inhalation 
studies.
    Immunotoxicity studies are not available for review. However, very 
slight mononuclear cell infiltrates in the heart are observed in only 
females (3/5) at the LOAEL of =5,000 ppm (approximately 
7,800 mg/kg/day human equivalent dose lowest dose tested) following 10 
days of exposure via inhalation in Sprague Dawley rats. This effect is 
not dose dependent with regard to either incidence or severity. Similar 
effects along with increased monocyte count are observed in the heart 
at 15,000 ppm (approximately 23,400 mg/kg/day human equivalent dose; 
HDT) in a 13-week study via inhalation in Sprague Dawley rats. The 
NOAEL is 5,000 ppm (equivalent to 7,800 mg/kg/day human equivalent 
dose). This study included more rats, is conducted in the same species 
of rats that underwent the same route of exposure and was of longer 
duration (13 weeks vs 10 days). Mononuclear cell infiltrates in the 
heart are not observed at 5,000 ppm (equivalent to 7,800 mg/kg/day 
human equivalent dose) in either the male or female rat as was observed 
in the 10-day study. Therefore, since the incidence and severity of 
these effects are not dose-dependent in the 10-day study, the 13-week 
study is considered more reflective of toxicity resulting from exposure 
to trans-1,3,3,3-tetrafluoroprop-1-ene. However, the Agency is not 
concerned about these effects since they occur well above the limit 
dose and exposure above that is highly unlikely and unrealistic.
    Two studies are available for trans-1,3,3,3-tetrafluoroprop-1-ene 
on male rats and mice metabolism and pharmacokinetics. In rats and 
mice, trans-1,3,3,3-tetrafluoroprop-1-ene via the inhalation route of 
exposure is rapidly absorbed, metabolized and excreted. The urine is 
the major route of excretion. In rats, the major metabolite is S-
(3,3,3-trifluoro-trans-propenyl)-mercaptolactic acid. In mice, the 
major metabolite is a presumed amino acid conjugate of 3, 3, 3-
trifluoropropionic acid. Other identified metabolites are S-(3, 3, 3-
trifluoro-transpropenyl)-L-cysteine, N-acetyl-S-(3,3,3-trifluoro-trans-
propenyl)-L-cysteine and 3,3,3-trifluoropropionic acid.
    Specific information on the studies received on trans-1,3,3,3-
tetrafluoroprop-1-ene as well as the no-observed-adverse-effect level 
(NOAEL) and the lowest- observed- adverse-effect level (LOAEL) from the 
toxicity studies can be found at https://www.regulations.gov in the 
document, ``Trans-1,3,3,3-tetrafluoroprop-1-ene; Human Health Risk 
Assessment and Ecological Effects Assessment to Support Proposed 
Exemption from the Requirement of a Tolerance When Used as Inert 
Ingredients in Pesticide Formulations'' in docket ID number EPA-HQ-OPP-
2012-0043.

B. Toxicological Points of Departure/Levels of Concern

    The available toxicity studies indicate that trans-1,3,3,3-
tetrafluoroprop-1-ene has very low overall toxicity. The lowest NOAEL 
in the database was 5,000 ppm (approximately 7,800 mg/kg/day human 
equivalent dose) observed in a 13 week toxicity study in rats via the 
inhalation route of exposure. Since signs of toxicity were not observed 
at well above the limit dose an endpoint of concern for risk assessment 
purposes was not identified.

C. Exposure Assessment

    1. Dietary exposure from food and feed uses. In evaluating dietary 
exposure to trans-1,3,3,3-tetrafluoroprop-1-ene, EPA considered 
exposure under the proposed exemption from the requirement of a 
tolerance. EPA assessed dietary exposures from trans-1,3,3,3-
tetrafluoroprop-1-ene in food as follows:

[[Page 61121]]

    The general population may be exposed via the diet to trans-
1,3,3,3-tetrafluoroprop-1-ene as a result of eating foods containing 
residues of trans-1,3,3,3-tetrafluoroprop-1-ene. However, since a 
hazard endpoint of concern was not identified for the acute and chronic 
dietary assessment (food and drinking water), a dietary exposure risk 
assessment was not conducted.
    2. From non-dietary exposure. The term ``residential exposure'' is 
used in this document to refer to non-occupational, non-dietary 
exposure (e.g., textiles (clothing and diapers), carpets, swimming 
pools, and hard surface disinfection on walls, floors, tables).
    The term ``residential exposure'' is used in this document to refer 
to non-occupational, non-dietary exposure (e.g., textiles (clothing and 
diapers), carpets, swimming pools, and hard surface disinfection on 
walls, floors, tables). Trans-1,3,3,3-tetrafluoroprop-1-ene may be used 
as an inert ingredient in pesticide products that could result in 
short- and intermediate-term residential exposure. However, based on 
the lack of toxicity, a quantitative exposure assessment from 
residential exposures was not performed.
    3. Cumulative effects from substances with a common mechanism of 
toxicity. Section 408(b)(2)(D)(v) of FFDCA requires that, when 
considering whether to establish, modify, or revoke a tolerance, the 
Agency consider ``available information'' concerning the cumulative 
effects of a particular pesticide's residues and ``other substances 
that have a common mechanism of toxicity.''
    EPA has not found trans-1,3,3,3-tetrafluoroprop-1-ene to share a 
common mechanism of toxicity with any other substances, and trans-
1,3,3,3-tetrafluoroprop-1-ene does not appear to produce a toxic 
metabolite produced by other substances. For the purposes of this 
tolerance action, therefore, EPA has assumed that trans-1,3,3,3-
tetrafluoroprop-1-ene does not have a common mechanism of toxicity with 
other substances. For information regarding EPA's efforts to determine 
which chemicals have a common mechanism of toxicity and to evaluate the 
cumulative effects of such chemicals, see EPA's Web site at https://www.epa.gov/pesticides/cumulative.

D. Safety Factor for Infants and Children

    Section 408(b)(2)(C) of FFDCA provides that EPA shall apply an 
additional tenfold (10X) margin of safety for infants and children in 
the case of threshold effects to account for prenatal and postnatal 
toxicity and the completeness of the database on toxicity and exposure 
unless EPA determines based on reliable data that a different margin of 
safety will be safe for infants and children. This additional margin of 
safety is commonly referred to as the Food Quality Protection Act 
Safety Factor (FQPA SF). In applying this provision, EPA either retains 
the default value of 10X, or uses a different additional safety factor 
when reliable data available to EPA support the choice of a different 
factor.
    As part of its qualitative assessment, the Agency did not use 
safety factors for assessing risk, and no additional safety factor is 
needed for assessing risk to infants and children. Based on the lack of 
effects in subchronic and developmental toxicity studies, and an 
assessment of trans-1,3,3,3-tetrafluoroprop-1-ene, EPA has concluded 
that there are no toxicological endpoints of concern for the U.S. 
population, including infants and children.

E. Aggregate Risks and Determination of Safety

    Because no toxicological endpoints of concern were identified, EPA 
concludes that aggregate exposure to residues of trans-1,3,3,3-
tetrafluoroprop-1-ene will not pose a risk to the U.S. population, 
including infants and children, and that there is a reasonable 
certainty that no harm will result to the general population, or to 
infants and children from aggregate exposure to trans-1,3,3,3-
tetrafluoroprop-1-ene residues.

V. Other Considerations

A. Analytical Enforcement Methodology

    An analytical method is not required for enforcement purposes since 
the Agency is establishing an exemption from the requirement of a 
tolerance without any numerical limitation.

VI. Conclusions

    Therefore, an exemption from the requirement of a tolerance is 
established under 40 CFR 180.910, 180.930 and 180.940(a) for trans-
1,3,3,3-tetrafluoroprop-1-ene (CAS Reg. No. 29118-24-9) when used as an 
inert ingredient (propellant) in pesticide formulations applied to 
formulations applied to growing crops, raw agricultural commodities 
after harvest, and animals, and when used as an inert ingredient in 
antimicrobial pesticide formulations for food-contact surface 
sanitizing solutions, respectively.

VII. Statutory and Executive Order Reviews

    This action establishes exemptions from the requirement of a 
tolerance under FFDCA section 408(d) in response to a petition 
submitted to the Agency. The Office of Management and Budget (OMB) has 
exempted these types of actions from review under Executive Order 
12866, entitled ``Regulatory Planning and Review'' (58 FR 51735, 
October 4, 1993). Because this action has been exempted from review 
under Executive Order 12866, this action is not subject to Executive 
Order 13211, entitled ``Actions Concerning Regulations That 
Significantly Affect Energy Supply, Distribution, or Use'' (66 FR 
28355, May 22, 2001) or Executive Order 13045, entitled ``Protection of 
Children from Environmental Health Risks and Safety Risks'' (62 FR 
19885, April 23, 1997). This action does not contain any information 
collections subject to OMB approval under the Paperwork Reduction Act 
(PRA) (44 U.S.C. 3501 et seq.), nor does it require any special 
considerations under Executive Order 12898, entitled ``Federal Actions 
to Address Environmental Justice in Minority Populations and Low-Income 
Populations'' (59 FR 7629, February 16, 1994).
    Since tolerances and exemptions that are established on the basis 
of a petition under FFDCA section 408(d), such as the exemptions in 
this final rule, do not require the issuance of a proposed rule, the 
requirements of the Regulatory Flexibility Act (RFA) (5 U.S.C. 601 et 
seq.), do not apply.
    This action directly regulates growers, food processors, food 
handlers, and food retailers, not States or tribes, nor does this 
action alter the relationships or distribution of power and 
responsibilities established by Congress in the preemption provisions 
of FFDCA section 408(n)(4). As such, the Agency has determined that 
this action will not have a substantial direct effect on States or 
tribal governments, on the relationship between the national government 
and the States or tribal governments, or on the distribution of power 
and responsibilities among the various levels of government or between 
the Federal Government and Indian tribes. Thus, the Agency has 
determined that Executive Order 13132, entitled ``Federalism'' (64 FR 
43255, August 10, 1999) and Executive Order 13175, entitled 
``Consultation and Coordination with Indian Tribal Governments'' (65 FR 
67249, November 9, 2000) do not apply to this action. In addition, this 
action does not impose any enforceable duty or

[[Page 61122]]

contain any unfunded mandate as described under Title II of the 
Unfunded Mandates Reform Act (UMRA) (2 U.S.C. 1501 et seq.).
    This action does not involve any technical standards that would 
require Agency consideration of voluntary consensus standards pursuant 
to section 12(d) of the National Technology Transfer and Advancement 
Act (NTTAA) (15 U.S.C. 272 note).

VIII. Congressional Review Act

    Pursuant to the Congressional Review Act (5 U.S.C. 801 et seq.), 
EPA will submit a report containing this rule and other required 
information to the U.S. Senate, the U.S. House of Representatives, and 
the Comptroller General of the United States prior to publication of 
the rule in the Federal Register. This action is not a ``major rule'' 
as defined by 5 U.S.C. 804(2).

List of Subjects in 40 CFR Part 180

    Environmental protection, Administrative practice and procedure, 
Agricultural commodities, Pesticides and pests, Reporting and 
recordkeeping requirements.

    Dated: October 1, 2015.
Susan Lewis,
Director, Registration Division, Office of Pesticide Programs.

    Therefore, 40 CFR chapter I is amended as follows:

PART 180--[AMENDED]

0
1. The authority citation for part 180 continues to read as follows:

    Authority:  21 U.S.C. 321(q), 346a and 371.

0
2. In Sec.  180.910, add alphabetically the inert ingredient to the 
table to read as follows:


Sec.  180.910  Inert ingredients used pre- and post-harvest; exemptions 
from the requirement of a tolerance.

----------------------------------------------------------------------------------------------------------------
               Inert ingredients                      Limits                            Uses
----------------------------------------------------------------------------------------------------------------
 
                                                  * * * * * * *
Trans-1,3,3,3-tetrafluoroprop-1-ene (CAS Reg.   ..................  Propellant.
 No. 29118-24-9).
 
                                                  * * * * * * *
----------------------------------------------------------------------------------------------------------------


0
3. In Sec.  180.930 add alphabetically the inert ingredient to the 
table to read as follows:


Sec.  180.930  Inert ingredients applied to animals; exemptions from 
the requirement of a tolerance.

----------------------------------------------------------------------------------------------------------------
               Inert ingredients                      Limits                            Uses
----------------------------------------------------------------------------------------------------------------
 
                                                  * * * * * * *
Trans-1,3,3,3-tetrafluoroprop-1-ene (CAS Reg.   ..................  Propellant.
 No. 29118-24-9).
 
                                                  * * * * * * *
----------------------------------------------------------------------------------------------------------------


0
4. In Sec.  180.940(a), add alphabetically the inert ingredient to the 
table to read as follows:


Sec.  180.940  Tolerance exemptions for active and inert ingredients 
for use in antimicrobial formulations (Food-contact surface sanitizing 
solution).

    (a) * * *

----------------------------------------------------------------------------------------------------------------
              Pesticide chemical                   CAS Reg. No.                        Limits
----------------------------------------------------------------------------------------------------------------
 
                                                  * * * * * * *
Trans-1,3,3,3-tetrafluoroprop-1-ene...........         29118-24-9   None.
 
                                                  * * * * * * *
----------------------------------------------------------------------------------------------------------------

* * * * *
[FR Doc. 2015-25690 Filed 10-8-15; 8:45 am]
 BILLING CODE 6560-50-P